Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04635735 · TERMINATED
Trial details
- NCT number
- NCT04635735
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-12
- Primary completion
- 2023-02-02
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.